<DOC>
	<DOCNO>NCT00003637</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know whether radiation therapy alone effective radiation therapy plus chemotherapy treating cancer nasopharynx . PURPOSE : This randomized phase III trial study well radiation therapy chemotherapy work compare radiation therapy alone treat patient previously untreated cancer nasopharynx .</brief_summary>
	<brief_title>Radiation Therapy Alone Compared Radiation Therapy Plus Chemotherapy Treating Patients With Previously Untreated Cancer Nasopharynx</brief_title>
	<detailed_description>OBJECTIVES : - Compare clinical response , distant metastasis , disease-free survival , overall survival patient previously untreated , locally advanced , nonmetastatic nasopharyngeal cancer treat radiotherapy alone vs concurrent chemoradiotherapy follow adjuvant chemotherapy . OUTLINE : This randomize study . Patients randomize receive radiotherapy alone ( arm I ) concurrent chemoradiotherapy follow adjuvant chemotherapy ( arm II ) . - Arm I : Patients receive radiotherapy daily 5 time week 7 week . - Arm II : Patients receive cisplatin IV 6-8 hour 4 consecutive day every 3 week 3 course . Concurrent radiotherapy give daily 5 time week 7 week treatment period . This chemoradiotherapy follow 3 week later adjuvant chemotherapy . Patients receive cisplatin IV fluorouracil IV 6-8 hour 4 consecutive day every 4 week 3 course . Patients follow every 4 month first year , every 6 month next 2 year , annually thereafter death . PROJECTED ACCRUAL : A minimum 200 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm nasopharyngeal cancer previously untreated WHO Type III Stage III/IV ( T34 Nx M0 Tx N23 M0 ) confirm CT PNS No evidence distant metastasis detect chest xray , bone scan , liver ultrasound PATIENT CHARACTERISTICS : Age : Not specify Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : WBC great 3,000/mm^3 Platelet count great 100,000/mm^3 Hepatic : SAP SGOT less 2 time upper limit normal Bilirubin le 1.4 mg/dL Renal : Creatinine le 1.6 mg/dL Creatinine clearance great 50 mL/min Other : No malignant disease PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other See Disease Characteristics No concurrent aminoglycoside antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
</DOC>